Compare ONTF & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONTF | QTRX |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.0M | 306.0M |
| IPO Year | 2021 | 2017 |
| Metric | ONTF | QTRX |
|---|---|---|
| Price | $7.98 | $6.75 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $7.40 | ★ $11.33 |
| AVG Volume (30 Days) | 530.8K | ★ 617.6K |
| Earning Date | 02-24-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $141,348,000.00 | $130,203,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $28.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.35 | $4.05 |
| 52 Week High | $8.10 | $10.28 |
| Indicator | ONTF | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 78.90 | 46.60 |
| Support Level | $7.95 | $6.84 |
| Resistance Level | $8.07 | $7.45 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 20.83 | 14.32 |
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.